Leerink Not Surprised by CEO Change at Endo Int'l (ENDP); Affirms at 'Market Perform'
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Leerink affirms Endo Int'l (Nasdaq: ENDP) at Market Perform with a price target of $22 following news of a key executive change.
The firm commented today,
This morning ENDP announced that Rajiv De Silva will step down as CEO and be replaced by Paul Campanelli, the former President of ENDP’s Generic and OTC division. Mr. Campanelli will also join ENDP’s board of directors and Mr. De Silva will step down from the board. In our view, the news doesn’t come as a surprise given ENDP’s stock performance and strategic shift toward a generic-focused portfolio. ENDP is making no changes to 2H’16 financial guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Analogic (ALOG) CEO Green Resigns; Successor Named
- Susquehanna Cuts Price Target on KLA-Tencor (KLAC) Following Strong 1Q
- Oppenheimer Raises Price Target on Microsoft (MSFT) to $65 Following 1Q Beat
Create E-mail Alert Related CategoriesAnalyst Comments, Management Changes
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!